Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanisms of renal hyporesponsiveness to BNP in heart failure.
Egom EE, Feridooni T, Hotchkiss A, Kruzliak P, Pasumarthi KB. Egom EE, et al. Among authors: pasumarthi kb. Can J Physiol Pharmacol. 2015 Jun;93(6):399-403. doi: 10.1139/cjpp-2014-0356. Epub 2015 Feb 26. Can J Physiol Pharmacol. 2015. PMID: 25881664 Review.
Role of D-type cyclins in heart development and disease.
Hotchkiss A, Robinson J, MacLean J, Feridooni T, Wafa K, Pasumarthi KB. Hotchkiss A, et al. Among authors: pasumarthi kb. Can J Physiol Pharmacol. 2012 Sep;90(9):1197-207. doi: 10.1139/y2012-037. Epub 2012 Aug 17. Can J Physiol Pharmacol. 2012. PMID: 22900666 Review.
A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure.
Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Pasumarthi KBS, Ribama HA. Egom EE, et al. Biomed Pharmacother. 2017 Sep;93:1144-1150. doi: 10.1016/j.biopha.2017.07.027. Epub 2017 Jul 19. Biomed Pharmacother. 2017. PMID: 28738523
New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease.
Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Rose RA, Pasumarthi KB, Ribama HA. Egom EE, et al. Among authors: pasumarthi kb. Int J Physiol Pathophysiol Pharmacol. 2017 Sep 1;9(4):112-118. eCollection 2017. Int J Physiol Pathophysiol Pharmacol. 2017. PMID: 28951773 Free PMC article.
Erratum: New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease.
Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Rose RA, Pasumarthi KB, Ribama HA. Egom EE, et al. Among authors: pasumarthi kb. Int J Physiol Pathophysiol Pharmacol. 2017 Nov 1;9(5):164. eCollection 2017. Int J Physiol Pathophysiol Pharmacol. 2017. PMID: 29218116 Free PMC article.
53 results